Who manufactures the Felocel vaccine for cats?

Who manufactures the Felocel vaccine for cats? - briefly

Felocel vaccine is manufactured by Boehringer Ingelheim, a global pharmaceutical company with a strong presence in the veterinary medicine sector. The company is known for its commitment to animal health and innovative solutions in veterinary care. Boehringer Ingelheim's portfolio includes a wide range of products designed to protect and improve the health of animals, with a particular focus on prevention and treatment of infectious diseases. The development and production of the Felocel vaccine align with the company's dedication to advancing veterinary medicine and ensuring the well-being of pets worldwide.

Who manufactures the Felocel vaccine for cats? - in detail

The Felocel vaccine, also known as Fel-O-Vax, is a feline leukemia vaccine designed to protect cats from feline leukemia virus (FeLV). This vaccine is manufactured by Boehringer Ingelheim Vetmedica Inc., a subsidiary of the global pharmaceutical company Boehringer Ingelheim. Boehringer Ingelheim is renowned for its extensive research and development in veterinary medicine, ensuring the production of high-quality and effective veterinary products.

Boehringer Ingelheim Vetmedica Inc. has a robust history in veterinary healthcare, focusing on the development of vaccines, pharmaceuticals, and diagnostic tools for companion animals. The company's commitment to innovation and quality is evident in its portfolio of products, which are designed to improve the health and well-being of pets worldwide. The Felocel vaccine is a testament to this commitment, providing cats with a crucial line of defense against FeLV.

The manufacturing process of the Felocel vaccine adheres to stringent quality control measures. Boehringer Ingelheim ensures that each batch of the vaccine meets the highest standards of safety and efficacy. This involves rigorous testing at various stages of production, from the initial development of the antigen to the final formulation of the vaccine. The company's state-of-the-art facilities and advanced manufacturing technologies further ensure the consistency and reliability of the vaccine.

In addition to manufacturing, Boehringer Ingelheim Vetmedica Inc. provides comprehensive support to veterinarians and pet owners. This includes educational resources, training programs, and customer support to ensure the proper administration and understanding of the Felocel vaccine. The company's dedication to veterinary education helps veterinarians stay informed about the latest advancements in feline healthcare, enabling them to provide the best possible care for their feline patients.

The Felocel vaccine is part of a broader range of veterinary products offered by Boehringer Ingelheim. These products are designed to address various health concerns in cats, including infectious diseases, parasites, and other medical conditions. The company's extensive research and development efforts continue to drive the creation of new and improved veterinary solutions, further enhancing the health and longevity of companion animals.

In summary, the Felocel vaccine for cats is manufactured by Boehringer Ingelheim Vetmedica Inc., a subsidiary of Boehringer Ingelheim. The company's commitment to quality, innovation, and veterinary education ensures that the Felocel vaccine is a reliable and effective tool in protecting cats from feline leukemia virus. Through its advanced manufacturing processes and comprehensive support, Boehringer Ingelheim Vetmedica Inc. continues to be a leader in veterinary healthcare, dedicated to improving the lives of pets and their owners.